Mirae Asset Global Investments Co., Ltd. Cytek Biosciences, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

  • $22.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
BUY
$9.71 - $15.86 $14,302 - $23,361
1,473 Added 3.1%
49,053 $500,000
Q3 2022

Nov 10, 2022
BUY
$10.96 - $15.45 $160,235 - $225,879
14,620 Added 44.36%
47,580 $700,000
Q2 2022

Jul 26, 2022
BUY
$7.41 - $11.56 $244,233 - $381,017
32,960 New
32,960 $354,000

Others Institutions Holding CTKB

# of Institutions
134
Shares Held
71.7M
Call Options Held
400
Put Options Held
0
View Full List

About Cytek Biosciences, Inc.

CTKB Quotes by TradingView
  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $851M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email